1. Choe, H. et al.

The -chemokine receptors CCR3 and CCR5 facilitate infection by

primary HIV-1 isolates. Cell 85, 11351148 (1996).
2. Cullen BR. Role and mechanism of action of the APOBEC3 family of antiretroviral
3.

resistance factors. J Virol 2006;80:10671076.

Cullen, B.R. Trans-activation of human immunodeficiency virus occurs via abimodal

mechanism. Cell 46, 973982 (1986).

4. Dalgleish, A.G. et al. The CD4 (T4) antigen is an essential component of the receptor for
the AIDS retrovirus. Nature 312, 763767 (1984).
5. Dragic, T. et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptorCCCKR-5. Nature 381, 667673 (1996).
6. Frankel AD, Young JAT. HIV-1: Fifteen proteins and an RNA. Annu Rev Biochem 1998;
67:125.
7. Garrus, J.E. et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV1 budding. Cell 107, 5565 (2001).
1) Hui Zhang, Yijun Zhang et al, A novel HIV-1-encoded microRNA enhances its
viral

replication

by

targeting

the

TATA

boxregion;

Retrovirology

2014, 11:23 doi:10.1186/1742-4690-11-23.

8. Jalaguier P, Cantin R, Maaroufi H, Tremblay MJ. Selective acquisition of host-derived
ICAM-1 by HIV-1 is a matrix-dependent process. Journal of Virology, 02701-14.
9. Kalpana, G.V., Marmon, S., Wang, W., Crabtree, G.R. & Goff, S.P. Binding and
stimulation of HIV-1 integrase by a human homolog of yeast transcription factorSNF5.
Science 266, 20022006 (1994).
10. Kinoshita, S., Chen, B.K., Kaneshima, H. & Nolan, G.P. Host control of HIV-1 parasitism
in T cells by the nuclear factor of activated T cells. Cell 95, 595604(1998).
11. Klatzmann, D. et al. T-lymphocyte T4 molecule behaves as the receptor for human
retrovirus LAV. Nature 312, 767768 (1984).
12. Neville, M., Stutz, F., Lee, L., Davis, L.I. & Rosbash, M. The importin- family member
Crm1p bridges the interaction between Rev and the nuclear pore complexduring nuclear
export. Curr. Biol. 7, 767775 (1997).

13. Phanuphak et al. 1985; Zeng et al. 1986; Simoes et al. 1987 The HIV-1 epidemic: Low to
middle income countries.
14. Pierson T, McArthur J, Siliciano RF. Reservoirs for HIV-1: Mechanisms for viral
persistence in the presence of antiviral immune responses and antiretroviral therapy.
Annu Rev Immunol 2000; 18:665708.
15. Piot et al. 1984; van de Perre et al. 1984; Serwadda et al. 1985 HIV- AIDS in Africa:
Distinguishing fact and fiction.
16. Tang H, Kuhen KL, Wong-Staal F. Lentivirus replication and regulation. Annu Rev Genet
1999; 33:133170.
17. VerPlank, L. et al. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds
the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. USA 98,77247729 (2001).
18. Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H. & Jones, K.A. A novel CDK9associated C-type cyclin interacts directly with HIV-1 Tat and mediates its
highaffinity,loop-specific binding to TAR RNA. Cell 92, 451462 (1998).
19. Zimmerman, C. et al. Identification of a host protein essential for assembly of immature
HIV-1 capsids. Nature 415, 8892 (2002).
20. The Gap Report; UNAIDS- 2014.
21. Ayouba, A., S. Souquieres, B. Njinku, P. M. Martin, M. C. MullerTrutwin, P. Roques, F. Barre-Sinoussi, P. Mauclere, F. Simon, and E.
Nerrienet. 2000. HIV-1 group N among HIV-1-seropositive individuals in
Cameroon. AIDS 14:2623-2625.[PubMed]

22.

L.

Buonaguro, M.

L.

Tornesello, and F.

M.

Buonaguro;

Human

Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic:

Pathogenetic and Therapeutic Implications; Journal of Virology- Oct 2007; 81(19):
1020910219.)
23. Mark A et al, Novel HIV-1 MiRNAs Stimulate TNF Release in Human Macrophages
via

TLR8

Signaling

Pathway;

PLoS

One. 2014

Sep

5;9(9):e106006.

doi:

10.1371/journal.pone.0106006.)
24. Jalaguier P, Cantin R, Maaroufi H, Tremblay MJ. Selective acquisition of host-derived
ICAM-1 by HIV-1 is a matrix-dependent process. Journal of Virology, 02701-14).